Intravitreal Bevacizumab for Age-Related Macular Degeneration
Intravitreal Bevacizumab Therapy for Neovascular Age-Related Macular Degeneration: A Pilot Study
Sponsor: Asociación para Evitar la Ceguera en México
Terminated
undefined
Other terminated trials from Asociación para Evitar la Ceguera en México
- Epiretinal Membrane · Phase PHASE3 · Feb 2014
- Proliferative Diabetic Retinopathy · Phase NA · Mar 2013
- Neovascular Glaucoma · Phase NA · Feb 2013
- Pain · Phase EARLY_PHASE1 · May 2010
- Vitrectomy · May 2010
See all terminations from Asociación para Evitar la Ceguera en México
Other Age Related Macular Degeneration trials with similar outcome
Listed as NCT00347165, this PHASE2 trial focuses on Age Related Macular Degeneration and remains terminated or withdrawn. Sponsored by Asociación para Evitar la Ceguera en México, it has been updated 7 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Terminated PHASE2
Status: Unknown Status → Terminated
-
Jan 2021 — Jun 2024 [monthly]
Unknown Status PHASE2
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE2
First recorded
Sep 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Asociación para Evitar la Ceguera en México
For direct contact, visit the study record on ClinicalTrials.gov .